LIFECODES® Non-HLA Antibody Assay
Expand your test capabilities.
LIFECODES offers the complete antibody product portfolio for the transplant laboratory, including kits designed to detect and identify non-HLA antibodies in serum.
LIFECODES® Non-HLA Antibody Assay Benefits
Clear
Results
Results
Easy
to Use
to Use
High
Efficiency
Efficiency
The Details
The development of post transplantation antibodies against Non-HLA autoantigens is associated with rejection and decreased long-term graft survival. The most convincing evidence of the importance of Non-HLA comes from reports of accelerated AMR in recipients of renal transplants from HLA identical siblings.
Werfen believes in advancing the field of transplantation with a greater understanding of the role of non-HLA in transplant rejection. LIFECODES Non-HLA Antibody kit detects IgG antibodies to 60 non-HLA autoantigens. The panel was selected from an exhaustive literature search and protoarray analysis.
Optimize Your Lab’s Performance
- Low antigen background allows for easy assignment of positive and negative results.
- An analysis tool helps to determine results.
- Results available in under 90 minutes.
LIFECODES Non-HLA Antibody kit is for Research Use Only (RUO). Not for use in diagnostic procedures.
LIFECODES® Non-HLA Antibody Assay Downloads
Resource Library
PACKAGE INSERTS (PI/ IFU), SAFETY DATA SHEETS (SDS), CERTIFICATES of ANALYSIS, LOT SPECIFIC FILES, and more can be accessed on our customer center.
Our Certifications
Experience Our Virtual Lab
Contact your sales representative for a personal tour.
Related Products
Upcoming Events,
Webinars & Workshops
Keep Up With Us
News & Blogs
Werfen Introduces NanoTYPE™ HLA-11 Plus CE— First CE-IVD HLA Typing Kit with Full-Gene Coverage for All 11 Classical HLA Genes
Werfen, a global leader in specialized diagnostics, announced the availability of NanoTYPETM HLA-11 Plus as CE-IVD (according to IVD-R), a next-generation HLA typing assay offering true full-gene coverage — from 5′UTR to 3′UTR — across all 11 classical HLA genes....
News & Blogs
Werfen acquires Omixon
Werfen has completed the acquisition of Omixon, a privately held company based in Budapest, Hungary,...
News & Blogs
PRESS RELEASE: Immucor and Pirche Announce Multi-Year Partnership
NORCROSS, Ga. and BERLIN, DE Oct. 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global...
News & Blogs
PRESS RELEASE: Immucor Announces New Innovations in Transplant Diagnostics
NORCROSS, Ga., March 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion...
News & Blogs
MIA FORATM NGS EXPRESS HLA Typing Software: You Spoke, We Listened!
Introducing MIA FORA NGS EXPRESS HLA Typing Software, Immucor’s next step in providing value-added user...
